Á lódáil...
Bevacizumab and CHOP (A-CHOP) in Combination for Patients with Peripheral T-Cell or Natural Killer Cell Neoplasms: An Eastern Cooperative Group Study (E2404)
Peripheral T-cell (PTCL) and NK cell lymphomas have poor survival with conventional cytotoxic chemotherapy. Because angiogenesis plays an important role in the biology of PTCL, a fully humanized anti-VEGF antibody, bevacizumab (A), was studied in combination with standard CHOP chemotherapy (ACHOP) t...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
2013
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3872505/ https://ncbi.nlm.nih.gov/pubmed/23786456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2013.816700 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|